FINWIRES · TerminalLIVE
FINWIRES

Rothschild & Co Redburn Downgrades Moderna to Sell From Neutral, Adjusts PT to $81 From $40

By

Moderna (MRNA) has an average rating of hold and mean price target of $108, according to analysts polled by FactSet.

What else is happening in Research?